36 filings
Page 2 of 2
6-K
gi8svhkjunsdo c7u
2 May 19
Kitov Announces Retirement of Founder and Executive Chairman Dr. Paul Waymack
4:46pm
6-K
78hnd7
29 Apr 19
Report of Foreign Private Issuer
4:29pm
6-K
mnwtehy6
15 Apr 19
Report of Foreign Private Issuer
7:20am
6-K
b8v3uzi8o5s yqtex
12 Apr 19
Report of Foreign Private Issuer
4:04pm
6-K
whoblx1rjvqjd
8 Apr 19
Proxy Statement - Annex A1
6:38am
6-K
g7jvm
1 Apr 19
Report of Foreign Private Issuer
6:47am
6-K
2jg 6ey51
22 Mar 19
Report of Foreign Private Issuer
4:30pm
6-K
5t53elmen9zajsvy
14 Mar 19
Notice of Special General Meeting of Shareholders
5:19pm
6-K
3mn6cwe
14 Mar 19
Kitov to Acquire Clinical Stage Candidate CM-24 Creating a Transformational Immuno-Oncology Company
9:28am
6-K
y9pw1hby45d9w1 hwr
11 Feb 19
Thank you CORPORATE PRESENTATION February 2019
4:47pm
6-K
bjr38t
7 Feb 19
Kitov Pharma Reports Year End 2018 Financial Results and Provides Business Update
8:08am
6-K
2l8858vx
18 Jan 19
Kitov Closes $6 Million Registered Direct Offering
5:22pm
6-K
prftsjcs 05
18 Jan 19
Report of Foreign Private Issuer
11:58am
6-K
4a21cd8rec pi3
16 Jan 19
Kitov Announces Pricing of $6 Million Registered Direct Offering
4:05pm
6-K
96bw4g
15 Jan 19
Report of Foreign Private Issuer
5:15pm
6-K
h42ag
3 Jan 19
Kitov Signs Marketing and Distribution Agreement for its Lead Product Consensiā¢ in the U.S. with Coeptis Pharmaceuticals
7:20am